MIRO News and Press, Miromatrix Medical Inc. From 05/25/22

EDEN PRAIRIE, Minn., May 25, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced that members of the management team will par...

EDEN PRAIRIE, Minn., May 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced its participation in the H.C. Wainwright Ann...

Miromatrix Medical Inc. (MIRO) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Hannah Jeffrey - Gilmartin Group LLC Jeff Ross - CEO Jim Douglas - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Presentation Operator Greetings and welcome to Mir...

Miromatrix Medical press release (NASDAQ:MIRO): Q1 GAAP EPS of -$0.35 misses by $0.06. Revenue of $6.77M (+10.8% Y/Y). "We continue to focus our efforts on advancing our bioengineered organs towards human clinical trials," said Jeff Ross, Ph.D., Miromatrix CEO. "The need for organ transp...

EDEN PRAIRIE, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today reported first quarter 2022 financial results an...

EDEN PRAIRIE, Minn., April 28, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that the Company will report financi...

EDEN PRAIRIE, Minn., April 19, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that CEO Jeff Ross will present at ...

Miromatrix Medical Inc. (MIRO) Q4 2022 Earnings Conference Call March 30 2022, 04:30 PM ET Company Participants Jeff Ross - CEO Jim Douglas - CFO Conference Call Participants Alex Novak - Craig-Hallum Capital Presentation Operator Greetings, and welcome to the Miromatrix Medical Fourth Quarte...

Miromatrix Medical press release (NASDAQ:MIRO): Q4 GAAP EPS of -$0.27 misses by $0.12. Revenue of $8K (-47.4% Y/Y). Shares -0.26%. For further details see: Miromatrix Medical GAAP EPS of -$0.27 misses by $0.12, revenue of $8M

EDEN PRAIRIE, Minn., March 30, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today reported fourth quarter and full year 2...